{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-017410","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2022-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.501163+00:00","generated_at":"2026-06-23T23:45:33.444157+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Palisade Bio reduces stockholder meeting quorum requirement from majority to one-third","bullets":["Board adopted amended bylaws on Aug 10, 2022 to lower quorum to one-third of outstanding common shares.","Change ensures company can achieve quorum at future stockholder meetings.","No material impact on business or operations expected from the bylaw amendment."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-017410","json":"https://secwatch.observer/filing/0000950170-22-017410.json","markdown":"https://secwatch.observer/filing/0000950170-22-017410.md","text":"https://secwatch.observer/filing/0000950170-22-017410.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000095017022017410/0000950170-22-017410-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000095017022017410/pali-20220810.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T23:45:33.444157+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}